Clinical Trial: Overall Survival Lengthened for Relapsed/Refractory Myeloma Patients Using CLR 13...
Feb 02, 2019
Myeloma patients who had relapsed after receiving both a proteasome inhibitor (like Velcade) and immunomodulator (like Revlimid)...
Feb 11, 2019
LIFE WITH MYELOMA
Feb 10, 2019
So you have multiple myeloma? Most people have never heard...
MUSCLES FOR MYELOMA
Muscles for Myeloma Columbus 5K and 1 Mile Walk 2019 – June 1 at Wolfe Park
Feb 12, 2019
We are delighted to host the 3rd annual Muscles for Myeloma 5K and 1 Mile Walk, Columbus, Ohio, honoring the Move MMORE Legacy, at Wolfe Park. About Muscles for Myeloma We’re building Muscles for Myeloma to help myeloma patients get moving and to...
Clinical Trial: GVAX Vaccine with Revlimid To Extend Remission
Jan 23, 2019
A new GVAX vaccine is being used in a clinical trial for myeloma patients who have achieved good responses to therapy. The goal of the trial is to extend remissions and potentially deepen responses to a minimal residual disease (MRD)...
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.
Today's myeloma therapies are yesterday's clinical trials and if more patients joined, we could accelerate a cure.Find a trial that's right for you using a myeloma clinical trial finder called SparkCures.
MYELOMA CROWD RESEARCH INITIATIVE
The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. The goal of the MCRI is to find and fund a cure for multiple myeloma.Learn More >
Thanks to our site sponsors: